Differential requirements for endosomal reduction in the presentation of two H2-Ed-restricted epitopes from influenza hemagglutinin

被引:30
作者
Sinnathamby, G
Maric, M
Cresswell, P
Eisenlohr, LC
机构
[1] Thomas Jefferson Univ, Kimmel Canc Inst, Dept Microbiol & Immunol, Philadelphia, PA 19107 USA
[2] Yale Univ, Sch Med, Howard Hughes Med Inst, Immunobiol Sect, New Haven, CT 06520 USA
关键词
D O I
10.4049/jimmunol.172.11.6607
中图分类号
R392 [医学免疫学]; Q939.91 [免疫学];
学科分类号
100102 ;
摘要
We examined the role of reduction in the presentation of two H2-E-d-restricted epitopes (site 1 epitope (S1) and site 3 epitope (S3)) occupying distinct domains of the influenza hemagglutinin major subunit that contains four intrachain disulfide bonds and is connected to the virion by one interchain bond. S3 is situated within the stalk region that unfolds in response to mild acidification, and loads onto recycling H2-E-d in the early endosome, while S1, located in the structurally constrained globular domain, loads onto nascent H2-E-d in the late endosome. Predicting dependence upon reduction for either epitope seemed plausible but the results from several approaches were clear: presentation of S1 but not S3 is reduction dependent. Surprisingly, IFN-gamma-inducible lysosomal thiol reductase (GILT), the only reductase thus far known to be involved in MHC class II-restricted processing, is not necessary for the generation of S1. However, GILT is necessary for presentation of either epitope when the virus is pretreated with a reducible cross-linker. The results suggest that unfolding of the Ag, perhaps a prerequisite for proteolytic processing in many cases, proceeds either spontaneously in the early endosome or via reduction in a later endosome. They further imply mechanisms for GILT-independent reduction in the late endosome, with GILT perhaps being reserved for more intractable Ags.
引用
收藏
页码:6607 / 6614
页数:8
相关论文
共 51 条
[1]   Enzymatic reduction of disulfide bonds in lysosomes: Characterization of a Gamma-interferon-inducible lysosomal thiol reductase (GILT) [J].
Arunachalam, B ;
Phan, UT ;
Geuze, HJ ;
Cresswell, P .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (02) :745-750
[2]   IN-VIVO AND IN-VITRO FORMATION AND DISSOCIATION OF HLA-DR COMPLEXES WITH INVARIANT CHAIN-DERIVED PEPTIDES [J].
AVVA, RR ;
CRESSWELL, P .
IMMUNITY, 1994, 1 (09) :763-774
[3]   3-DIMENSIONAL STRUCTURE OF THE HUMAN CLASS-II HISTOCOMPATIBILITY ANTIGEN HLA-DR1 [J].
BROWN, JH ;
JARDETZKY, TS ;
GORGA, JC ;
STERN, LJ ;
URBAN, RG ;
STROMINGER, JL ;
WILEY, DC .
NATURE, 1993, 364 (6432) :33-39
[4]   EFFICIENT LOADING OF IDENTICAL VIRAL PEPTIDE ONTO CLASS-II MOLECULES BY ANTIGENIZED IMMUNOGLOBULIN AND INFLUENZA-VIRUS [J].
BRUMEANU, TD ;
SWIGGARD, WJ ;
STEINMAN, RM ;
BONA, CA ;
ZAGHOUANI, H .
JOURNAL OF EXPERIMENTAL MEDICINE, 1993, 178 (05) :1795-1799
[5]   CLASS-II TRANSACTIVATOR REGULATES THE EXPRESSION OF MULTIPLE GENES INVOLVED IN ANTIGEN PRESENTATION [J].
CHANG, CH ;
FLAVELL, RA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1995, 181 (02) :765-767
[6]  
Chianese-Bullock KA, 1998, J IMMUNOL, V161, P1599
[7]  
COLLINS DS, 1991, J IMMUNOL, V147, P4054
[8]   ASSEMBLY, TRANSPORT, AND FUNCTION OF MHC CLASS-II MOLECULES [J].
CRESSWELL, P .
ANNUAL REVIEW OF IMMUNOLOGY, 1994, 12 :259-293
[9]   HLA-DM interactions with intermediates in HLA-DR maturation and a role for HLA-DM in stabilizing empty HLA-DR molecules [J].
Denzin, LK ;
Hammond, C ;
Cresswell, P .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (06) :2153-2165
[10]  
Dutch RE, 2000, BIOSCIENCE REP, V20, P597